1Y Annualised Return
▼-44.32%
3Y Annualised Return
▼-5.88%
5Y Annualised Return
▼-21.58%
10Y Annualised Return
▲18.82%
Genpharmasec Stock Performance
|
|
|
Genpharmasec Company background
Founded in: 1992
Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in Gujarat as Adi Rasayan Limited. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from Adi Rayasan Limited to Genpharmasec Limited on 27 November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited to Genpharmasec Limited on 25 October, 2021 a fresh Certificate of Incorporation upon the name change was obtained from the Registrar of Companies at Mumbai. The company is dealing primarily in pharmaceutical activities / services and trading in equity shares. The Company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, it started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, it shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In 2019, Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, iSTAT 1 Analyzer which is a handheld blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.In FY 202324, Company has obtained distribution rights from Abbott Point of Care, USA for distribution of their iSTAT Analysers and its Cartridges all over India. The Directors of the Company are consistently making efforts to expand the business activities as depending exclusively one Company would result in stagnation of sales in the coming years. Besides these efforts, Company has started directly importing Cartridges from Abbott POC, USA which has increased its profitability to a great extent.The Company has formed a whollyowned subsidiary namely, M/s. Clinigenome India Private Limited to establish clinical laboratories in various major cities to capture everexpanding and lucrative diagnostic segment. It also has established a subsidiary in Dubai, UAE in which Company holds 52% shareholding. The Company has on 25th July, 2025 acquired the 70% stake in Derren Healthcare Private Limited (DHPL), making DHPL a subsidiary of the Company.
Genpharmasec Financial Highlights
For the full year FY2025–2026, revenue
reached ₹36.78 crore and profit touched at
₹1.23 crore.
Genpharmasec Share Price Today
As of 4 Dec 2025, Genpharmasec share price is ₹1.5. The stock opened at ₹1.5 and had closed at ₹1.5 the previous day. During today’s trading session, Genpharmasec share price moved between ₹1.39 and ₹1.54, with an average price for the day of ₹1.46. Over the last 52 weeks, the stock has recorded a low of ₹1.39 and a high of ₹4.32. In terms of performance, Genpharmasec share price has declined by 30.5% over the past six months and has declined by 44.32% over the last year.
Genpharmasec SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹1,81,127 in 5 years with a gain of ₹-1,18,872 (-39.62%)
Genpharmasec Fundamental
Market Cap (in crs)
81.95
Face Value
1
Turnover (in lacs)
20.28
Key Metrics
Qtr Change %
New 52W Low today
-23.3
Dividend yield 1yr %
0
Genpharmasec Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Genpharmasec Quarterly Revenue
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
32.64 Cr | 12.04 Cr | 14.01 Cr | 8.48 Cr | 6.03 Cr |
Genpharmasec Yearly Revenue
| Mar 2025 | Mar 2024 |
|---|---|
36.78 Cr | 31.06 Cr |
Genpharmasec Quarterly Net Profit/Loss
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
-1.18 Cr | 1.22 Cr | -0.27 Cr | 0.78 Cr | 0.7 Cr |
Genpharmasec Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 |
|---|---|
1.23 Cr | -0.17 Cr |
Genpharmasec Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1.48
Current Price
Day EMA5
1.50
Day EMA10
1.50
Day EMA12
1.50
Day EMA20
1.50
Day EMA26
1.60
Day EMA50
1.70
Day EMA100
1.80
Day EMA200
2.00
Day SMA5
1.50
Day SMA10
1.50
Day SMA20
1.50
Day SMA30
1.60
Day SMA50
1.70
Day SMA100
1.80
Day SMA150
1.90
Day SMA200
2.00
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 834987 Rs | 1370132 Rs |
Week Rs | 365279 Rs | 527109 Rs |
Month Rs | 508798 Rs | 676222 Rs |
Resistance & Support
1.47
Pivot
Resistance
First Resistance
1.55
Second Resistance
1.62
Third Resistance
1.70
Support
First Support
1.40
Second support
1.32
Third Support
1.25
Relative Strength Index
39.91
Money Flow Index
46.14
MACD
-0.05
MACD Signal
-0.06
Average True Range
0.09
Average Directional Index
23.32
Rate of Change (21)
-7.50
Rate of Change (125)
-29.19
Genpharmasec Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
30.67 | 72.71 | 9.59 | 32.66 | 29.75 | 3.37% | 59.32% | 163.71% | 219.81% | 495.53% | 0.00% | 61.34 | 41.69 | 2.80 | |
261.90 | 80.92 | 245 | 449.45 | 260.00 | 2.59% | -8.27% | -25.41% | -35.26% | -63.36% | 0.38% | 51.56 | 41.69 | 1.14 | |
133.40 | 85.87 | 118.95 | 260 | 133.50 | -0.82% | -7.14% | -23.33% | -47.05% | -19.47% | 0.00% | 28.87 | 41.69 | 3.62 | |
70.00 | 71.78 | 60.55 | 94.9 | 70.15 | 0.00% | -5.37% | -2.78% | -7.89% | -22.14% | 0.00% | 57.85 | 85.54 | 1.24 | |
41.94 | 83.90 | 40 | 104.9 | 42.00 | -1.34% | -24.88% | -46.38% | 0.00% | 0.00% | 0.00% | 7.82 | 41.69 | 1.21 | |
98.99 | 84.26 | 75.21 | 126 | 104.62 | 5.92% | 19.77% | 0.00% | 0.00% | 0.00% | 0.00% | 22.10 | 41.69 | 2.18 |
Genpharmasec Share Price FAQs
How to buy Genpharmasec shares?
You can easily buy Genpharmasec shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Genpharmasec ?
The 52-week high and low of Genpharmasec share price is ₹4.32 and ₹1.39 as of 3/12/2025.
Please be aware that Genpharmasec stock prices are subject to continuous fluctuations due to various factors.
Invest in Genpharmasec